Skip to main content

Want a detailed portfolio tracker?

Nextcure (NXTC) P/E (2019 - 2026)

Nextcure (NXTC) P/E from May 9, 2019 to Jul 21, 2026. The TTM Nextcure (NXTC) P/E is -0.25. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nextcure (NXTC)

YearP/EChange
2026-0.25-60.42%
2025-0.64+65.90%
2024-0.39-19.89%
2023-0.48-8.02%
2022-0.53-78.00%
2021-2.39-70.88%
2020-8.20-78.11%
2019-37.47N/A

Comparison Nextcure (NXTC) P/E with competitors

Nextcure (NXTC) P/E is -0.25.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.67%
NBYStablecoin Development Corp0.00-101.69%
ENLVEnlivex Ltd0.07-129.42%
FGENFibroGen Inc0.24-194.42%
CHRSCoherus Biosciences Inc0.85-433.75%
FBIOFortress Biotech Inc0.95-473.28%
ORMPOramed Pharmaceuticals Inc1.50-691.20%
AGENAgenus Inc3.01-1283.77%
INVAInnoviva Inc3.15-1340.57%
VXRTVaxart Inc3.55-1496.21%
CRMDCorMedix Inc3.63-1527.17%
CVACCureVac N.V.4.45-1848.61%
GLPGGalapagos NV4.86-2011.14%
SRPTSarepta Therapeutics Inc4.88-2020.27%
ABEOAbeona Therapeutics Inc5.39-2219.06%
ABUSArbutus Biopharma Corp5.60-2300.92%
ZVRAZevra Therapeutics Inc5.89-2415.62%
SPROSpero Therapeutics Inc6.23-2549.82%
CGENCompugen Ltd6.31-2583.46%
RIGLRigel Pharmaceuticals6.87-2802.98%
SLXNSilexion Therapeutics Corp7.30-2969.76%
OMEROmeros Corporation9.26-3741.74%
AUPHAurinia Pharmaceuticals Inc9.58-3870.04%
PLXProtalix BioTherapeutics Inc10.89-4383.75%
ACADAcadia Pharmaceuticals Inc11.73-4713.18%
TBPHTheravance Biopharma Inc12.26-4923.06%
ADMAAdma Biologics Inc12.42-4984.43%
HRMYHarmony Biosciences Holdings Inc13.82-5535.89%
SABSSAB Biotherapeutics Inc14.14-5660.19%
NAGENiagen Bioscience Inc14.82-5928.41%
INCYIncyte Corp15.82-6323.49%
REGNRegeneron Pharmaceuticals Inc15.86-6336.90%
PBYIPuma Biotechnology Inc17.32-6910.79%
CPRXCatalyst Pharmaceuticals Inc17.44-6959.41%
EXELExelixis Inc17.54-6998.23%
TGTXTG Therapeutics Inc18.97-7559.92%
MDXGMimedx Group Inc20.55-8183.93%
XOMAXOMA Royalty Corp22.87-9097.54%
ARGXArgen X SE24.30-9657.39%
CTMXCytomX Therapeutics Inc24.82-9863.15%
XOMAOXOMA Royalty Corp25.34-10069.14%
HALOHalozyme Therapeutics Inc25.62-10178.85%
XOMAPXOMA Royalty Corp25.67-10197.10%
VRTXVertex Pharmaceuticals Inc27.99-11111.47%
RPRXRoyalty Pharma plc - Class A28.69-11383.97%
SLNOSoleno Therapeutics Inc29.02-11512.91%
ASNDAscendis Pharma A/S30.09-11933.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-15012.34%
APLSApellis Pharmaceuticals Inc39.02-15448.63%
BMRNBiomarin Pharmaceutical Inc42.21-16703.64%
KRYSKrystal Biotech Inc45.34-17935.43%
ONCBeiGene Ltd69.54-27453.10%
PHARPharming Group N.V.75.03-29610.63%
TECHBio-Techne Corp101.96-40204.40%
VCELVericel Corp109.92-43336.56%
ALNYAlnylam Pharmaceuticals Inc117.96-46500.50%
GMABGenmab140.29-55282.10%
TLXTelix Pharmaceuticals Ltd162.15-63881.34%
CORTCorcept Therapeutics Inc212.86-83825.57%